2022 Charleston HFpEF Conference
MUSC Cardiology
SGLT2 Inhibitors in HFpEF: Sifting Through Murky Data
FEATURING
Daniel Silverman
- 903 views
- November 9, 2022
- 5
MUSC Cardiology
Volume Management in the CardioRenal Syndrome
FEATURING
Harold Szerlip
- 651 views
- November 9, 2022
- 2
MUSC Cardiology
Water From a Stone: Overcoming Diuretic Resistance in HFpEF
FEATURING
Brian Houston
- 751 views
- November 8, 2022
- 8
MUSC Cardiology
The Underappreciated Problem of Sarcopenia and Frailty in HFpEF: Can It Be Treated?
FEATURING
Amanda Vest
- 40 views
- November 8, 2022
MUSC Cardiology
Social Determinants of Health Influence the Risk of HFpEF and Clinical Management
FEATURING
Alanna Morris
- 21 views
- November 8, 2022
MUSC Cardiology
Exercise and Diet as Therapy for Heart Failure with Preserved Ejection Fraction
FEATURING
Dalane Kitzman
- 474 views
- November 8, 2022
- 3
MUSC Cardiology
Guideline Recommendations for HFpEF
FEATURING
Biykem Bozkurt
- 1,190 views
- November 8, 2022
- 2
MUSC Cardiology
Preload Insufficiency: How Should It Be Diagnosed and Treated?
FEATURING
Ryan Tedford
- 684 views
- November 8, 2022
- 8
MUSC Cardiology
Inotropic Treatment for HFpEF? An Idea So Crazy It Just Might Be Right
FEATURING
Sheldon Litwin
- 1,079 views
- November 8, 2022
- 13
MUSC Cardiology
Lymphatic and Veins: The 2 Forgotten Vessels - The Future of HFpEF Therapeutics?
FEATURING
Marat Fudim
- 667 views
- November 8, 2022
- 10
MUSC Cardiology
It's Not the Heart! Impact of Pulmonary (Vascular) Disease in the HFpEF Patient
FEATURING
Rahul Argula
- 221 views
- November 8, 2022
- 3
MUSC Cardiology
Pulmonary Vascular Adaptations in HFpEF: Pathophysiology and Treatment
FEATURING
Barry Borlaug
- 39 views
- November 8, 2022
MUSC Cardiology
Update on Non-pharmacological Therapies for HFpEF: Atrial Shunt Devices and Greater Splanchnic Nerve Ablation
FEATURING
Sanjiv J. Shah
- 330 views
- November 8, 2022
- 1
MUSC Cardiology
The Spectrum of Pregnancy Associated Heart Failure: Is This a Form of HFpEF?
FEATURING
Bhavadharini Ramu
- 83 views
- November 8, 2022
- 1
MUSC Cardiology
Heart Failure Management Facilitated by Ambulatory, Continuous, Actionable Risk Metric(s)
FEATURING
Michael Zile
- 27 views
- November 8, 2022
MUSC Cardiology
Heart Rate as a Treatment of HFpEF
FEATURING
Markus Meyer
- 178 views
- November 8, 2022
- 1
MUSC Cardiology
Arterial Stiffness: Does It Contribute to HFpEF and How Do We Treat It?
FEATURING
Jennifer Ho
- 18 views
- November 8, 2022
MUSC Cardiology
Update on Cardiac Amyloidosis: Continued Evolution of Diagnosis and Treatment
FEATURING
Daniel Judge
- 237 views
- November 8, 2022
- 1